Scheme 1. Synthesis of Michael Addition Substrates
Figure 1. Michael acceptors employed in this study.
site.12 This mechanism was unambiguously demonstrated for
cruzain, the major cysteine protease associated with Trypa-
nosoma cruzi (Chagas’ disease), by three-dimensional struc-
tures of several enzyme-inhibitor complexes solved by
X-ray crystallography, which show the active site Cys-25
covalently bound in 1,4-fashion with respect to the vinyl
sulfonyl group of the inhibitor.12
Several vinyl sulfonyl inhibitors exhibit strikingly potent
inhibition kinetics against cruzain, while also demonstrating
potent in ViVo activities against T. cruzi.8,9 In fact, one vinyl
sulfone inhibitor targeting cruzain is capable of curing mice
infected by T. cruzi.13 A continuing goal of our collaboration
with the McKerrow and Rosenthal groups at UCSF is to
develop viable therapeutics for Chagas’ disease and malaria
by designing improved inhibitors that have better bioavail-
ability, lower host toxicity, and increased selectivity for the
parasites.
To understand the structural effects that give rise to very
potent inhibition of cruzain and related cysteine protases, it
is necessary to separate the binding constant (Ki) of the
inhibitor scaffold and rate constant of the irreversible
chemical step of inhibition (kinact) of various vinyl sulfonyl
derivatives. However, very fast inhibition rates for many of
our vinyl sulfonyl cysteine protease inhibitors have precluded
determination of kinact/Ki values; the majority of inhibition
of 2-hydroxyethanethiol to N-methyl-N-phenylvinylsulfona-
mide have also been reported.15 However, we are not aware
of any kinetic evaluation of the full array of vinyl sulfonyl
units reported in the cysteine protease inhibition literature.
An analysis of the Michael reactivity of the vinyl sulfonyl
derivatives should allow us to anticipate the magnitude of
kinact in the design of future generations of cysteine protease
inhibitors. We also expect that the data reported here may
be useful in situations where the Michael acceptor reactivities
of different vinyl sulfonyl functional groups can be exploited
in organic synthesis.11,17
The vinyl sulfonyl derivatives used in this study were
synthesized as summarized in Scheme 1, using chemistry
patterned after our syntheses of vinyl sulfonyl cysteine
protease inhibitors.8-10 Enone, enoate, and vinyl sulfonyl
groups were installed by stabilized Wittig and Horner-
Wadsworth-Emmons reactions to furnish compounds 2, 3,
4, and 7. The phenyl sulfonate ester 1 and the sulfonamides
5, 6, 8, and 9 were installed via base-promoted coupling of
phenol or the appropriate amine with the sulfonyl chloride
11.
constants from our previous work have been reported as kassoc
14
values,8,9 from which it is impossible to extract Ki and kinact
.
To assess the intrinsic reactivities of the Michael acceptors,
which presumably contribute to kinact for the enzyme inhibi-
tion reaction, we have carried out pseudo-first-order kinetic
analyses of Michael additions of 2′-(phenethyl)thiol to
inhibitor analogues 1-9 (Figure 1).
Mechanistic studies of base-catalyzed conjugate additions
of alcohols15 and the uncatalyzed addition of amines16 to
vinyl sulfones and vinyl sulfonamides have previously been
reported. The kinetics of the base-catalyzed Michael addition
(12) Brinen, L. S.; Hansell, E.; Cheng, J.; Roush, W. R.; McKerrow, J.
H.; Fletterick, R. J. Structure 2000, 8, 831.
(13) Engel, J. C.; Doyle, P. S.; Hsieh, I.; McKerrow, J. H. J. Exp. Med.
1998, 188, 725.
(14) Bieth, J. G. Methods Enzymol. 1995, 248, 59.
(15) Davies, W. G.; Hardisty, E. W.; Nevell, T. P.; Peters, R. H. J. Chem.
Soc. B 1970, 998.
Relative rates of base-promoted Michael additions of 2′-
phenethylthiol to acceptors 1-9 were measured by 1H NMR
(16) Davies, W. G.; Hardisty, E. W.; Nevell, T. P.; Peters, R. H. J. Chem.
Soc. B 1970, 1004.
(17) Morris, J.; Wishka, D. G. J. Org. Chem. 1991, 56, 3549.
Org. Lett., Vol. 5, No. 11, 2003
1968